Wording of Helicobacter pylori eradication therapy in selected summary-of-product-characteristics sections

Current effective version

PDF iconPoints to consider

Reference numberCPMP/EWP/863/98
Effective from01/03/2000
KeywordsHelicobacter pylori, summary of product characteristics (SmPC), non-NSAID induced gastro-duodenal ulcers
DescriptionThis document gives general consideration to the clinical evaluation of medicinal products intended for use in H. pylori eradication therapy. It provides guidance on the information to be included in the summary of product characteristics for these medicines.

Related content

How useful was this page?

Add your rating